Focus: Context Therapeutics is a Philadelphia-based biotechnology company focused on developing treatments for hormone-driven cancers, including breast, ovarian, and endometrial malignancies. The company operates at the pre-revenue clinical stage with a modest portfolio spanning oncology and endocrinology.
Profile data last refreshed 16h ago · AI intelligence enriched 3w ago
Stable — net -1 jobs in 30d
0 added, 1 removed. Backfill posture.
Context Therapeutics offers scientifically compelling oncology work in a focused, early-stage environment, but career security depends heavily on private funding trajectory and pipeline advancement milestones.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Context Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Context Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo